Covid19 – Novavax begins vaccine trials on kids
US biotech agency Novavax mentioned Monday it had began medical trials of its proposed Covid-19 vaccine on kids, in a program that may contain as much as 3,000 adolescents aged 12-17. Contributors will likely be monitored for as much as two years after their injections.
Learn additionally – FDA to authorise Pfizer vaccines for adolescents
Far fewer kids have been sick with Covid-19 in comparison with adults, and most have delicate to no signs, however they are often contaminated and unfold the virus.
The Novavax vaccine, which makes use of completely different expertise from the doses already extensively licensed all over the world, is a protein-based vaccine engineered from the genetic sequence of the primary pressure of the coronavirus.
The Novavax vaccine has not but been approved in any nation, together with for adults, however the firm plans to file for emergency authorization in Britain “within the second quarter of 2021”, adopted by in america.
Different vaccine firms together with Moderna, Johnson & Johnson and Pfizer are additionally conducting trials in adolescents.